Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study
Diabetes, Obesity and Metabolism · 2025-10 · 27 (10) · 5921-5929
DOI: 10.1111/dom.16649 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 29.07.2025. Verfasst von Wenhao Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Obesity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 82473730.
Abstract (Originalsprache)
Aims
The obesity paradox has been controversial and is mostly observed when body mass index (BMI) is used. We aimed to examine the presence of the obesity paradox using body fatness (body fat percentage, BF%) and central obesity (waist‐to‐hip ratio adjusted for BMI, WHRadjBMI). We also used Mendelian randomisation to explore causality for the associations of BMI, BF% and WHRadjBMI with cardiovascular disease (CVD) mortality. Materials and Methods A total of 85 926 participants with CVD from the UK Biobank were included. Prospective associations of BMI, BF% and WHRadjBMI with CVD mortality in these patients were examined. Polygenic risk scores (PRSs) for BMI, BF% and WHRadjBMI were used as instrumental variables in Mendelian randomisation analyses.
Results
A total of 5432 patients died of CVD causes during a median follow‐up period of 13.6 years. BMI in the overweight and class‐I obesity ranges was associated with reduced mortality, with class‐II or more severe obesity associated with increased mortality; however, there was a linear trend toward increased mortality with increasing BF% and WHRadjBMI. There was no clear indication that increased obesity‐PRSs were associated with reduced risk of CVD mortality among patients with known CVD. Sensitivity analyses by sex, age group and disease type, and by using a single variant from the FTO gene rs1558902 as an instrumental variable showed similar results.
Conclusion
Increased obesity does not show a protective effect in patients with CVD. Previously reported obesity paradox in observational studies may be a result of confounding or other biases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Institute for Medical Dataology, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Cancer Epidemiology and Prevention Research, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, Canada.
- Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Department of Epidemiology, Tulane University School of Public Health, New Orleans, Louisiana, USA.
- Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.
ORCID-Profile: Tao Zhang, Fuzhong Xue, Shengxu Li
Förderung
- National Natural Science Foundation of China
- 82473730
Zitieren
APA
Yu, W., Fan, B., Yang, L., Si, S., Chen, W., Zhang, T., Xue, F., & Li, S. (2025). Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study. Diabetes, Obesity and Metabolism, 27(10), 5921-5929. https://doi.org/10.1111/dom.16649
Vancouver
Yu W, Fan B, Yang L, Si S, Chen W, Zhang T, et al. Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study. Diabetes, Obesity and Metabolism. 2025;27(10):5921-5929. doi:10.1111/dom.16649
BibTeX
@article{Yu2025,
author = {Yu, Wenhao and Fan, Bingbing and Yang, Lin and Si, Shucheng and Chen, Wei and Zhang, Tao and Xue, Fuzhong and Li, Shengxu},
title = {Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {10},
pages = {5921--5929},
doi = {10.1111/dom.16649}
}
EUVIMED